文献速递神经核医学

新型PET示踪剂18F-脱氧硫胺素:合成、代谢动力学及脑硫胺素代谢状态评估

A novel PET tracer 18F-deoxy-thiamine: synthesis, metabolic kinetics, and evaluation on cerebral thiamine metabolism status.
PubMed 文献 · EJNMMI Res · 2020-10-20

本研究合成新型PET示踪剂18F-脱氧硫胺素,在 mice 和 marmosets 中评估其代谢动力学及脑硫胺素代谢状态。示踪剂体外体内稳定,脑内摄取在硫胺素缺乏小鼠中显著升高,marmosets脑内AUC与血硫胺素二磷酸水平负相关。结论认为该示踪剂满足理想PET示踪剂要求,可用于在体检测脑硫胺素代谢状态。

要点

  • 18F-脱氧硫胺素体外体内稳定,小鼠肝、肾摄取快清除快。
  • 硫胺素缺乏小鼠脑内示踪剂滞留显著高于对照。
  • marmosets脑内60分钟AUC与血硫胺素二磷酸水平负相关。

核心结论

  • 18F-脱氧硫胺素满足理想PET示踪剂要求,可用于在体检测脑硫胺素代谢状态。

研究设计与样本

  • 通过两步法自动化模块合成18F-脱氧硫胺素,用HPLC评估比活度和放射化学纯度等质控参数。
  • 用micro-PET/CT研究小鼠和marmosets脑内代谢动力学,用HPLC和γ计数器测定小鼠体内稳定性、肾排泄率和生物分布。
  • 分析60分钟内脑内示踪剂滞留AUC与血硫胺素水平的相关性。

主要发现

  • 18F-脱氧硫胺素体外和体内均稳定。
  • 小鼠肝1分钟内SUVmax达4.61±0.53,肾半分钟内达18.67±7.04,注射后60分钟肝和肾SUV分别降至0.72±0.05和0.77±0.35。
  • 注射后肾、肝和胰腺高积聚,脑、肌肉、脂肪和性腺低积聚,与既往硫胺素分布报道一致。
  • 注射后90分钟内,硫胺素缺乏C57BL/6小鼠脑内18F-脱氧硫胺素水平为对照的1.9倍,ICR小鼠为3.1倍。
  • marmosets脑内60分钟AUC为29.33±5.15,与血硫胺素二磷酸水平负相关(r=-0.985,p=0.015)。

临床怎么用

  • 该示踪剂有望用于在体评估脑硫胺素代谢状态,辅助相关神经心理疾病的诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Some neuropsychological diseases are associated with abnormal thiamine metabolism, including Korsakoff-Wernicke syndrome and Alzheimer's disease. However, in vivo detection of the status of brain thiamine metabolism is still unavailable and needs to be developed. METHODS: A novel PET tracer of 18F-deoxy-thiamine was synthesized using an automated module via a two-step route. The main quality control parameters, such as specific activity and radiochemical purity, were evaluated by high-performance liquid chromatography (HPLC). Radiochemical concentration was determined by radioactivity calibrator. Metabolic kinetics and the level of 18F-deoxy-thiamine in brains of mice and marmosets were studied by micro-positron emission tomography/computed tomography (PET/CT). In vivo stability, renal excretion rate, and biodistribution of 18F-deoxy-thiamine in the mice were assayed using HPLC and γ-counter, respectively. Also, the correlation between the retention of cerebral 18F-deoxy-thiamine in 60 min after injection as represented by the area under the curve (AUC) and blood thiamine levels was investigated. RESULTS: The 18F-deoxy-thiamine was stable both in vitro and in vivo. The uptake and clearance of 18F-deoxy-thiamine were quick in the mice. It reached the max standard uptake value (SUVmax) of 4.61 ± 0.53 in the liver within 1 min, 18.67 ± 7.04 in the kidney within half a minute. The SUV dropped to 0.72 ± 0.05 and 0.77 ± 0.35 after 60 min of injection in the liver and kidney, respectively. After injection, kidney, liver, and pancreas exhibited high accumulation level of 18F-deoxy-thiamine, while brain, muscle, fat, and gonad showed low accumulation concentration, consistent with previous reports on thiamine distribution in mice. Within 90 min after injection, the level of 18F-deoxy-thiamine in the brain of C57BL/6 mice with thiamine deficiency (TD) was 1.9 times higher than that in control mice, and was 3.1 times higher in ICR mice with TD than that in control mice. The AUC of the tracer in the brain of marmosets within 60 min was 29.33 ± 5.15 and negatively correlated with blood thiamine diphosphate levels (r = - 0.985, p = 0.015). CONCLUSION: The 18F-deoxy-thiamine meets the requirements for ideal PET tracer for in vivo detecting the status of cerebral thiamine metabolism.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Wang C, Zhang S, Zou Y, et al. A novel PET tracer 18F-deoxy-thiamine: synthesis, metabolic kinetics, and evaluation on cerebral thiamine metabolism status. EJNMMI Res. 2020. PMID: 33079296. doi:10.1186/s13550-020-00710-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。